Dissemin is shutting down on January 1st, 2025

Published in

American Chemical Society, ACS Medicinal Chemistry Letters, 5(11), p. 977-983, 2020

DOI: 10.1021/acsmedchemlett.0c00014

Links

Tools

Export citation

Search in Google Scholar

Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells

Journal article published in 2020 by Annalisa Romanelli, Giulia Stazi, Rossella Fioravanti, Clemens Zwergel ORCID, Elisabetta Di Bello, Silvia Pomella ORCID, Clara Perrone, Cecilia Battistelli, Raffaele Strippoli, Marco Tripodi, Donatella del Bufalo ORCID, Rossella Rota, Daniela Trisciuoglio, Antonello Mai ORCID, Sergio Valente ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO